GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Protara Therapeutics Inc (FRA:1KPA) » Definitions » Total Operating Expense

Protara Therapeutics (FRA:1KPA) Total Operating Expense : €47.75 Mil (TTM As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is Protara Therapeutics Total Operating Expense?

Protara Therapeutics's Total Operating Expense for the three months ended in Mar. 2025 was €13.07 Mil. Protara Therapeutics's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was €47.75 Mil.

Protara Therapeutics Total Operating Expense Historical Data

The historical data trend for Protara Therapeutics's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Protara Therapeutics Total Operating Expense Chart

Protara Therapeutics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Operating Expense
Get a 7-Day Free Trial 28.31 42.03 35.44 39.99 46.94

Protara Therapeutics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.90 9.90 11.11 13.67 13.07

Protara Therapeutics Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €47.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Protara Therapeutics Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Protara Therapeutics's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Protara Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Protara Therapeutics Inc (FRA:1KPA) » Definitions » Total Operating Expense
Comparable Companies
VTYX NKTR LRMR LYEL HURA SEER ALEC NKTX ENTA EXOZ VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
TARA:USA
Address
345 Park Avenue South, 3rd Floor, New York, NY, USA, 10010
Website
https://www.protaratx.com
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Protara Therapeutics Headlines

No Headlines